Vietnam Liver Cancer Elimination

Investment Overview

💡 Smart Funding Model

Since January 2019, Vietnam's health insurance covers 50% of Hepatitis treatment costs (HBV + HCV). This reduces net cash requirements significantly.

Total Program Value $35.2M

Vietnam Gov Insurance (HBV+HCV 50%) - $4.0M

Net Cash Investment Needed $31.2M

Funding Structure ($31.2M)

💼 Impact Investors

$20M

65% of funding

Patient capital funds
Healthcare mission investors
Impact-focused family offices
Aligned with social + financial returns

🎁 Grants & Foundations

$8M

25% of funding

International health organizations
Corporate CSR programs
Philanthropic foundations
No return expected

💰 Revenue (Year 4-6)

$3.2M

10% of funding

Patient revenue begins Year 4
Corporate screening contracts
Research partnerships
Self-sustaining trajectory

Phase 1 (Year 1-6): Foundation Building

🎯 Financial Outcome

Break-even trajectory by Year 6
Revenue growing from minimal to sustainable levels
Operating costs stabilized

Year 6 Status: Self-sustaining operations ready for commercial expansion

💚 Social Impact

1,000

Lives Saved

$50M+

Healthcare Savings

🏆 Strategic Assets (Most Important!)

✅ Established brand as "medical excellence"
✅ Government trust & regulatory relationships
✅ Hospital partnerships across 5 cities
✅ 100,000 patient database
✅ Operational infrastructure worth $6.7M
✅ Proven AI platform & trained staff

Additional Value Opportunities

Beyond direct patient care, this program creates several high-value assets. As medical professionals focused on clinical outcomes, we have not fully quantified these opportunities. We welcome investor expertise in identifying optimal commercialization strategies.

🔬 Proprietary Medical Database

13,000+ patients with 6-year longitudinal tracking creates world-class dataset:

Viral hepatitis progression patterns
Cancer development timelines
Treatment response data
Real-world clinical outcomes

Potential applications: Pharmaceutical research partnerships, biotech collaborations, AI algorithm training, clinical trial recruitment, real-world evidence generation

🤖 AI Healthcare Platform

Proven technology with demonstrated efficiency (10x capacity at 1/5 cost):

Scalable to other diseases beyond liver cancer
Applicable across Southeast Asia region
Licensing opportunities to hospitals and clinics
SaaS platform potential

🌐 Network Effects & Platform Business

Infrastructure and relationships enable multiple expansion paths:

Corporate wellness programs
Telemedicine network
Medical tourism opportunities
Insurance partnerships
Government contract potential

💼 Strategic Market Position

First-mover advantage in AI-powered cancer screening
Market entry platform for $20B Vietnam healthcare market (10% CAGR)
Replicable model across Southeast Asia (Cambodia, Laos, Myanmar, Philippines)
Foundation for comprehensive health services expansion

Long-Term Growth Trajectory

📈 Phase 2 (Year 7-10): Commercial Expansion

Expansion Strategy:

Multi-cancer screening: Leverage existing CT/MRI for gastric, colorectal, breast, lung, cervical cancer
Premium health services: VIP comprehensive health checkups, executive wellness programs
Corporate partnerships: Large-scale employee screening programs
Data monetization: Research collaborations, pharmaceutical partnerships

Expected outcome: Sustainable, profitable operations with multiple revenue streams. Exact financial projections depend on execution and market conditions, but path to significant commercial success is clear.

🚀 Phase 3 (Year 10-15): Market Leadership

Multiple pathways to market-leading position:

Path A: Vietnam Nationwide

Expand from 5 cities to 10+ cities, comprehensive cancer centers, establish as Vietnam's premier cancer screening network

Path B: Regional Platform

Replicate proven Vietnam model to Cambodia, Laos, Myanmar. AI platform licensing, regional healthcare network

Path C: Healthcare + Tech Platform

Evolve into technology-enabled healthcare company with AI/data business, SaaS platform licensing, potential for public markets

Our focus: Delivering clinical excellence in Phase 1.
Your expertise: Optimizing commercial strategy for Phases 2-3.

Investment Philosophy

We are medical professionals committed to saving 1,000 lives while building sustainable healthcare infrastructure. We have structured this program for clinical excellence and identified clear paths to commercial success. We welcome experienced investors to help optimize the business model and unlock additional value opportunities we have not fully explored.

Vietnam Impact

Part 3: Investment Structure